Literature DB >> 6832181

Detection of acute myocardial infarction in spontaneously hypertensive rats by 99mTc-pyrrolidino methyl tetracycline.

B Zmbova, D Stojanova, D Stakic, I Tadzer, V Bogdanova.   

Abstract

The myocardial infarct induced by isoproterenol in spontaneously hypertensive rats accumulates higher activities of 99mTc-PM tetracycline compared with the cardiac infarct in normotensive rats caused by the same method. The isoproterenol model of the myocardial necrosis was induced in intact rats without opening the thorax and is a convenient method for experimental radioisotope studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832181     DOI: 10.1007/bf00263506

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

2.  An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.

Authors:  G RONA; C I CHAPPEL; T BALAZS; R GAUDRY
Journal:  AMA Arch Pathol       Date:  1959-04

3.  The preparation and control of pyrrolidino-methyl tetracycline labelled with 99mTc.

Authors:  B Zmbova; D Zivanov-Stakić; I Tadzer; V Bogdanova
Journal:  Int J Appl Radiat Isot       Date:  1978-06

4.  Radionuclide imaging of experimental myocardial contusion.

Authors:  R T Go; C L Chiu; D B Doty; H F Cheng; J H Christie
Journal:  J Nucl Med       Date:  1974-12       Impact factor: 10.057

5.  The specificity of the diffuse pattern of cardiac uptake in myocardial infarction imaging with technetium-99m stannous pyrophosphate.

Authors:  R Prasquier; M R Taradash; E H Botvinick; D M Shames; W W Parmley
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

Review 6.  Myocardial infarct imaging with technetium-99m phosphates.

Authors:  R W Parkey; F J Bonte; L M Buja; E M Stokely; J T Willerson
Journal:  Semin Nucl Med       Date:  1977-01       Impact factor: 4.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.